Clinical Trials
5 trialsNCT05103358 2024-06-03
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)
Aadi Bioscience, Inc.
Phase 2 Unknown
NCT04163419 2024-03-13
Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis
Massachusetts General Hospital
Phase 2 Unknown
NCT05750693 2023-03-02
PIK3CA in HER2+ BC and pCR Trial
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase NA Unknown
NCT03781050 2019-01-23
Efficacy of Rapamycin (Sirolimus) in the Treatment of Peutz-Jeghers Syndrome
Peking Union Medical College Hospital
Phase 4 Unknown
NCT01341834 2018-04-24
Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors
National Cancer Centre, Singapore
Phase 1 Unknown